| 重组人脑利钠肽治疗心力衰竭 |
| |
| 引用本文： | 张善春,刘兆昶. 重组人脑利钠肽治疗心力衰竭[J]. 中国心血管杂志, 2006, 11(6): 477-478,F0003 |
| |
| 作者姓名： | 张善春 刘兆昶 |
| |
| 作者单位： | 天津市第三医院心内科,天津,300250 |
| |
| 摘 要： | 大量对照临床试验表明,对急性失代偿性心力衰竭患者,外源性给予一种基因重组人脑利钠肽(nesiritide)可以改善临床症状和血流动力学状况,还能够有效抑制神经内分泌的激活。
|
| 关 键 词： | 基因重组人脑利纳肽 脑利钠肽 治疗 心力衰竭 |
| 文章编号： | 1007-5410（2006）06-0477-03 |
| 收稿时间： | 2006-03-03 |
| 修稿时间： | 2006-03-032006-04-28 |
Recombinant human brain natriuretic peptide in the treatment of heart failure |
| |
| ZHANG Shan-chun,LIU Zhao-chang. Recombinant human brain natriuretic peptide in the treatment of heart failure[J]. Chinese Journal of Cardiovascular Medicine, 2006, 11(6): 477-478,F0003 |
| |
| Authors: | ZHANG Shan-chun LIU Zhao-chang |
| |
| Affiliation: | Department of Cardiology, the Third Hospital of Tianjin , Tianjin 300250, China |
| |
| Abstract: | Many, controlled clinical trials have shown that exogenously administered nesiritide , a recombinant human brain natriuretic peptide, in patients with acute decompensated heart failure not only reduce symptoms and improves acute hemodynamics, but also suppresses neurohormonal activation. |
| |
| Keywords: | Nesiritide Brain natriuretic peptid Treatment Heart failure |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
